Prevalence, Treatment, and Outcomes of Corneal Disease in Aboriginal and Torres Strait Islander Peoples in Australia: A Systematic Review

BACKGROUND: To synthesise available evidence on the prevalence, treatment strategies, and outcomes of corneal disease affecting Aboriginal and Torres Strait Islander peoples in Australia, and to identify gaps in the existing literature. METHODS: A systematic review with narrative synthesis was conducted in accordance with PRISMA 2020 guidelines. PubMed, Embase, Scopus, and the Cochrane Library were searched from January 2010 to February 2025. Eligible studies reported epidemiology and/or treatment outcomes of corneal disease in Indigenous Australians. Due to heterogeneity, meta-analysis was not performed. RESULTS: Twenty-one studies met inclusion criteria. Active trachoma prevalence declined over the past decade from approximately 14%-15% (1-5) to 3%-4% (6-8), with most jurisdictions reporting prevalence below endemic thresholds by 2022, although pockets of higher prevalence persisted in some remote communities (8). Trachomatous trichiasis was higher among Indigenous Australian adults compared with non-Indigenous Australian adults (~0.4%-0.5% vs. ~0.03%-0.05%) (5, 8, 9). Evidence for non-trachomatous corneal disease was limited to clinic and hospital-based cohort studies. These data suggested that pterygium was common among Indigenous Australians, although lacked population-level prevalence estimates. Hospital-based keratitis cohorts demonstrated worse visual outcomes among Indigenous patients, with distinct risk factor profiles characterised by lower contact lens use and higher rates of trauma and delayed presentation. CONCLUSIONS: While available data suggest progress in some corneal conditions among Indigenous Australians, major evidence gaps limit reliable estimates for several pathologies. Priorities include strengthening Indigenous-specific population data and developing prevention and treatment approaches tailored to environmental exposures and access barriers in remote communities.

Authors

Institutions

Publication Details

Journal
Clinical and Experimental Ophthalmology
Published
2026-04-13
DOI
https://doi.org/10.1111/ceo.70118
Primary Topic
Ocular Infections and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevalence, Treatment, and Outcomes of Corneal Disease in Aboriginal and Torres Strait Islander Peoples in Australia: A Systematic Review

Daniel Cool, Angus van der Nagel, Stephanie Watson, Himal Kandel
Clinical and Experimental Ophthalmology
Ocular Infections and Treatments
article

Prevalence, Treatment, and Outcomes of Corneal Disease in Aboriginal and Torres Strait Islander Peoples in Australia: A Systematic Review

Daniel Cool, Angus van der Nagel, Stephanie Watson, Himal Kandel
article en

Abstract

BACKGROUND: To synthesise available evidence on the prevalence, treatment strategies, and outcomes of corneal disease affecting Aboriginal and Torres Strait Islander peoples in Australia, and to identify gaps in the existing literature. METHODS: A systematic review with narrative synthesis was conducted in accordance with PRISMA 2020 guidelines. PubMed, Embase, Scopus, and the Cochrane Library were searched from January 2010 to February 2025. Eligible studies reported epidemiology and/or treatment outcomes of corneal disease in Indigenous Australians. Due to heterogeneity, meta-analysis was not performed. RESULTS: Twenty-one studies met inclusion criteria. Active trachoma prevalence declined over the past decade from approximately 14%-15% (1-5) to 3%-4% (6-8), with most jurisdictions reporting prevalence below endemic thresholds by 2022, although pockets of higher prevalence persisted in some remote communities (8). Trachomatous trichiasis was higher among Indigenous Australian adults compared with non-Indigenous Australian adults (~0.4%-0.5% vs. ~0.03%-0.05%) (5, 8, 9). Evidence for non-trachomatous corneal disease was limited to clinic and hospital-based cohort studies. These data suggested that pterygium was common among Indigenous Australians, although lacked population-level prevalence estimates. Hospital-based keratitis cohorts demonstrated worse visual outcomes among Indigenous patients, with distinct risk factor profiles characterised by lower contact lens use and higher rates of trauma and delayed presentation. CONCLUSIONS: While available data suggest progress in some corneal conditions among Indigenous Australians, major evidence gaps limit reliable estimates for several pathologies. Priorities include strengthening Indigenous-specific population data and developing prevention and treatment approaches tailored to environmental exposures and access barriers in remote communities.

Clinical and Experimental Ophthalmology
The University of Sydney (AU)
Openalex Percentile: Top 12%
Ocular Infections and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Prevalence, Treatment, and Outcomes of Corneal Disease in Aboriginal and Torres Strait Islander Peoples in Australia: A Systematic Review — Daniel Cool, Angus van der Nagel, et al. · Clinical and Experimental Ophthalmology (2026) | TGRS Research Map | TGRS